Bristol Myers Squibb (BMY) Net Margin (2009 - 2026)
Bristol Myers Squibb (BMY) reported Net Margin of 23.32% for Q1 2026, up 134.0% year-over-year from 9.96% in Q1 2025, and up 168.44% on a QoQ basis from 8.69% in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Net Margin data on file, last reported at 23.32% in Q1 2026.
- Quarterly Net Margin rose 134.0% year-over-year to 23.32% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.0% (up 382.0% YoY) and the FY2025 annual result came in at 14.64%, up 3314.0% from the prior year.
- Net Margin rose to 23.32% in Q1 2026 per BMY's latest filing, from 8.69% in the prior quarter.
- Across five years, Net Margin topped out at 23.32% in Q1 2026 and bottomed at 100.36% in Q1 2024.
- The 5-year median for Net Margin is 14.33% (2022), against an average of 7.77%.
- The widest annual swing landed in 2024, when Net Margin slumped 12036 bps; it then soared 12234 bps in 2025.
- Tracing BMY's Net Margin over 5 years: stood at 17.75% in 2022, then fell by 16 bps to 14.87% in 2023, then plunged by 96 bps to 0.62% in 2024, then jumped by 1311 bps to 8.69% in 2025, then jumped by 168 bps to 23.32% in 2026.
- Per Business Quant, the three latest BMY Net Margin figures stand at 23.32% (Q1 2026), 8.69% (Q4 2025), and 17.96% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 37.36% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 21.76% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 4.65% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -25.84% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 21.11% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 29.04% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -0.56% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 23.32% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.32% |
| Dec 31, 2025 | 8.69% |
| Sep 30, 2025 | 17.96% |
| Jun 30, 2025 | 10.70% |
| Mar 31, 2025 | 21.98% |
| Dec 31, 2024 | 0.62% |
| Sep 30, 2024 | 9.73% |
| Jun 30, 2024 | 13.36% |
| Mar 31, 2024 | -100.36% |
| Dec 31, 2023 | 14.87% |
| Sep 30, 2023 | 17.64% |
| Jun 30, 2023 | 18.50% |
| Mar 31, 2023 | 20.00% |
| Dec 31, 2022 | 17.75% |
| Sep 30, 2022 | 14.33% |
| Jun 30, 2022 | 12.02% |
| Mar 31, 2022 | 11.01% |
| Dec 31, 2021 | 19.79% |
| Sep 30, 2021 | 12.74% |
| Jun 30, 2021 | 8.50% |
| Mar 31, 2021 | 17.71% |
| Dec 31, 2020 | -91.14% |
| Sep 30, 2020 | 17.13% |
| Jun 30, 2020 | -1.44% |
| Mar 31, 2020 | -7.72% |
| Dec 31, 2019 | -14.60% |
| Sep 30, 2019 | 20.98% |
| Jun 30, 2019 | 21.31% |
| Mar 31, 2019 | 27.30% |
| Dec 31, 2018 | 17.78% |
| Sep 30, 2018 | 31.66% |
| Jun 30, 2018 | 4.93% |
| Mar 31, 2018 | 26.61% |
| Dec 31, 2017 | -44.69% |
| Sep 30, 2017 | 13.80% |
| Jun 30, 2017 | 15.55% |
| Mar 31, 2017 | 28.55% |
| Dec 31, 2016 | 13.89% |
| Sep 30, 2016 | 21.27% |
| Jun 30, 2016 | 21.10% |
| Mar 31, 2016 | 23.71% |
| Dec 31, 2015 | -8.07% |
| Sep 30, 2015 | 13.17% |
| Jun 30, 2015 | -6.68% |
| Mar 31, 2015 | 26.13% |
| Dec 31, 2014 | -2.44% |
| Sep 30, 2014 | 17.19% |
| Jun 30, 2014 | 7.25% |
| Mar 31, 2014 | 23.04% |
| Dec 31, 2013 | 14.70% |
| Sep 30, 2013 | 17.32% |
| Jun 30, 2013 | 13.04% |
| Mar 31, 2013 | 15.22% |
| Dec 31, 2012 | 21.69% |
| Sep 30, 2012 | -19.08% |
| Jun 30, 2012 | 24.62% |
| Mar 31, 2012 | 28.22% |
| Dec 31, 2011 | 24.20% |
| Sep 30, 2011 | 25.35% |
| Jun 30, 2011 | 24.05% |
| Mar 31, 2011 | 27.28% |
| Dec 31, 2010 | -25.85% |
| Sep 30, 2010 | 27.14% |
| Jun 30, 2010 | 19.38% |
| Mar 31, 2010 | 22.90% |
| Dec 31, 2009 | 143.35% |
| Sep 30, 2009 | 1.90% |
| Jun 30, 2009 | 18.76% |
| Mar 31, 2009 | 0.02% |